Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. In prostate cancer, this gene has increased expression, which indicates its possible use as a diagnostic or prognostic marker for prostate cancer. The gene contains multiple polyadenylation sites and alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2008].
Yousef, Scorilas, Katsaros, Fracchioli, Iskander, Borgono, Rigault de la Longrais, Puopolo, Massobrio, Diamandis: "Prognostic value of the human kallikrein gene 15 expression in ovarian cancer." in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 21, Issue 16, pp. 3119-26, (2003) (PubMed).
Yousef, Scorilas, Magklara, Memari, Ponzone, Sismondi, Biglia, Abd Ellatif, Diamandis: "The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer." in: British journal of cancer, Vol. 87, Issue 11, pp. 1294-300, (2002) (PubMed).
Diamandis, Yousef: "Human tissue kallikrein gene family: a rich source of novel disease biomarkers." in: Expert review of molecular diagnostics, Vol. 1, Issue 2, pp. 182-90, (2002) (PubMed).